Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in ALEC — Alector, Inc.

CIK 1603466 STAMFORD, CT
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$53,664
-$118,531 QoQ
Shares Held
26,699
-66.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 140 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Derivatives in ALEC

reported options exposure · as of Sep 30, 2025
CallValue
$37,592
CallShares
12,700
PutValue
$37,592
PutShares
12,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ALEC ranks #157 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in ALEC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $53,664 26,699
2026-03-31 $172,195 80,091
2025-12-31 $36,039 23,102
2025-09-30 $37,592 12,700
2025-09-30 $1,604 542
2025-09-30 $37,592 12,700
2024-09-30 $393,947 84,538
2024-06-30 $2,789,307 614,385
2024-03-31 $4,185,706 695,300
2023-12-31 $1,109,220 139,000
2023-09-30 $4,787,307 738,782
2023-06-30 $10,404,199 1,731,148
2023-03-31 $8,253,386 1,333,342
2022-09-30 $1,033,032 109,200
2020-06-30 $7,045,147 288,263